WeightWatchers slims down after shedding another key piece

Founded over six decades ago, WeightWatchers (WW) was initially often known as a subscription-based weight loss program consisting of easy-to-follow meal plans that were aimed at helping clients live more healthy lives by losing excess weight.

On the alternative hand, a couple of the most modern hack for celebrities and the well off to remain slim hasn't remained a secret for too long, as more public figures have begun confessing their use of GLP-1 medications.

Related: Tiger Woods business venture hits a rough patch

GLP-1 medications, which encompass Ozempic (NONOF) , Wegovy, and Trulicity, are prescribed semaglutide injectables most often administered to patients with type 2 diabetes and, most recently, to treat obesity.

These drugs are supposed to block sugar production within the liver, eventually suppressing appetite and promoting weight loss.

The rage for these weight loss injections began to take over WeightWatchers' clientele just as fast as they made people shed multiple pounds.

But, because the saying goes, within the event you may not beat them, subscribe to them, and WeightWatchers took the primary opportunity to hop on.

WeightWatchers enters the weight loss drugs game

In March 2023, the company that once praised the ability of eating regimen and calorie counting to promote weight loss made up our minds to enter the prescription drug business, specifically GLP-1 drugs.

Whatever the actual undeniable fact that it completely contradicted what WeightWatchers (WW) had promoted for just a couple of years, the company closed a $106 million deal to amass Sequence.

Sequence, now often known as WeightWatchers Clinic, is a comprehensive prescription weight-loss program that grants WeightWatchers' clients get entry to to GLP-1 medications to assist them in sustaining weight loss.

This acquisition was completed not best this can be because company desired to keep up with the logo new weight loss trend but additionally because it has been struggling to make ends meet for your time.

As of Monday, WeightWatchers' stock has dropped over ninety% YTD.

Per WeightWatchers' Q2 2024 earnings report, subscription revenues declined by around 6%, with total revenues dropping nearly eleven% when compared with the year prior.

End-of-period subscribers fell by over 6% versus last year, but clinical subscribers, who're those subscribed to WeightWatchers Clinic to receive GLP-1 medications, increased by nearly A hundred and twenty%.

Whatever the undeniable undeniable fact that most sectors had declining results, GLP-1 prescription drugs continue to be triumphant within the weight loss market.

WeightWatchers executive quits all instantly, and the company doesn't  give a reason

On Friday, WeightWatchers announced that Sima Sistani would instantly leave her role as CEO after a two-year run.

Sistani served as CEO at some stage within the company's transition into the weight loss medication business and actively supported the change.

On the alternative hand, WeightWatchers has yet to publicly specify why the now-former CEO made up our minds to resign and leave instantly.

More Retail:

• Amazon gets sued by renowned retailer for cyber web famous dupes
• Denny's hops on the ex-exec trend after 'Grand Slam' failure
• Nike's DTC leads company back to a well-known ex

After the announcement was made, the company's stock decreased by nearly Three%.

Whatever the undeniable undeniable fact that a giant setback for the company, WeightWatchers stock increased by 5.Three% on Monday.

On the alternative hand, it truly seriously won't ever be the primary time a board member has all instantly left WeighWatchers.

Oprah Winfrey leaves WeightWatchers after revealing a shocking secret

In February, WeightWatchers announced Oprah Winfrey, who had served on the board since 2015, would leave the company instantly.

Whatever the undeniable undeniable fact that Winfrey also had a sudden departure from the company, she couldn't leave without doing one last good deed to mark her legacy on a project she had spent so many years of her life promoting.

Winfrey donated all 10% of her stake within the company to the National Museum of African American History and Culture in Washington.

Related: Oprah makes a prime move after weight loss drug controversy

In December 2023, Winfrey revealed that she had been using weight loss medications and left the company because she didn't want any conflict of interest related to her new journey.

While on "Jimmy Kimmel Live!", Winfrey also announced An Oprah Special: Shame, Blame and The Weight Loss Revolution, where she would sit down down with health workers and patients to talk about weight loss drugs.

She attributed her transition to realizing that weight loss was not about self-control but rather a mental state that she couldn't get out of.

"It occupied 5 decades of space in my brain, yo-yoing and feeling like why can’t I just conquer this thing, believing self-control was my failing," said Winfrey in an interview.

"Obesity is a disease. It’s not about self-control — it truly is in regards to the brain."

Related: Veteran fund manager sees world of pain coming for stocks